Company · founded 2014
Sab Biotherapeutics (United States)
Sioux Falls, United States · sabbiotherapeutics.com
- Citations, last 5 years
- 81
- Works, last 5 years
- 18
- h-index
- 27
- Scientists listed
- 3
- Grants since 2016
- 5
Grants received
2019–2022 · research · R44
Advancing a Candidate Human Polyclonal Anti-Thymocyte Globulin Product Produced in Transchromosomal Bovine for Transplant Induction/Acute Rejection and T1D Therapy
Alexei Yurievitch Savinov · Sab Biotherapeutics (United States) · funded by National Institutes of Health
2019 · research · R44
Advancing a Candidate Human Polyclonal Anti-Thymocyte Globulin Product Produced in Transchromosomal Bovine for Transplant Induction/Acute Rejection and T1D Therapy
Alexei Yurievitch Savinov · Sab Biotherapeutics (United States) · funded by National Institutes of Health
2019–2021 · research · R44
Advancing a Candidate Human Polyclonal Anti-Thymocyte Globulin Product Produced in Transchromosomal Bovine for Transplant Induction/Acute Rejection and T1D Therapy
Alexei Yurievitch Savinov · Sab Biotherapeutics (United States) · funded by National Institutes of Health
2016–2018 · research · R44
Production of therapeutic human polyclonal antibodies against influenza viruses
Victor Chester Huber · Sab Biotherapeutics (United States) · funded by National Institutes of Health
2016–2019 · research · R44
Production of therapeutic human polyclonal antibodies against influenza viruses
Christoph Bausch · Sab Biotherapeutics (United States) · funded by National Institutes of Health
